NO610
发表于 2025-3-21 17:08:09
书目名称Case-Based Lessons in the Management of Complex Hepato-Pancreato-Biliary Surgery影响因子(影响力)<br> http://impactfactor.cn/2024/if/?ISSN=BK0222315<br><br> <br><br>书目名称Case-Based Lessons in the Management of Complex Hepato-Pancreato-Biliary Surgery影响因子(影响力)学科排名<br> http://impactfactor.cn/2024/ifr/?ISSN=BK0222315<br><br> <br><br>书目名称Case-Based Lessons in the Management of Complex Hepato-Pancreato-Biliary Surgery网络公开度<br> http://impactfactor.cn/2024/at/?ISSN=BK0222315<br><br> <br><br>书目名称Case-Based Lessons in the Management of Complex Hepato-Pancreato-Biliary Surgery网络公开度学科排名<br> http://impactfactor.cn/2024/atr/?ISSN=BK0222315<br><br> <br><br>书目名称Case-Based Lessons in the Management of Complex Hepato-Pancreato-Biliary Surgery被引频次<br> http://impactfactor.cn/2024/tc/?ISSN=BK0222315<br><br> <br><br>书目名称Case-Based Lessons in the Management of Complex Hepato-Pancreato-Biliary Surgery被引频次学科排名<br> http://impactfactor.cn/2024/tcr/?ISSN=BK0222315<br><br> <br><br>书目名称Case-Based Lessons in the Management of Complex Hepato-Pancreato-Biliary Surgery年度引用<br> http://impactfactor.cn/2024/ii/?ISSN=BK0222315<br><br> <br><br>书目名称Case-Based Lessons in the Management of Complex Hepato-Pancreato-Biliary Surgery年度引用学科排名<br> http://impactfactor.cn/2024/iir/?ISSN=BK0222315<br><br> <br><br>书目名称Case-Based Lessons in the Management of Complex Hepato-Pancreato-Biliary Surgery读者反馈<br> http://impactfactor.cn/2024/5y/?ISSN=BK0222315<br><br> <br><br>书目名称Case-Based Lessons in the Management of Complex Hepato-Pancreato-Biliary Surgery读者反馈学科排名<br> http://impactfactor.cn/2024/5yr/?ISSN=BK0222315<br><br> <br><br>
Affirm
发表于 2025-3-21 22:07:58
http://image.papertrans.cn/c/image/222315.jpg
傲慢人
发表于 2025-3-22 03:50:04
https://doi.org/10.1007/978-1-4615-5477-6ve planning of minimally invasive hepatectomy. The multidisciplinary management of metastatic colorectal cancer is discussed. We review existing data regarding the feasibility, safety, and oncologic outcomes following minimally invasive hepatic resection for malignancy.
Cryptic
发表于 2025-3-22 08:07:24
Minimally Invasive Resection of Colorectal Liver Metastasesve planning of minimally invasive hepatectomy. The multidisciplinary management of metastatic colorectal cancer is discussed. We review existing data regarding the feasibility, safety, and oncologic outcomes following minimally invasive hepatic resection for malignancy.
malapropism
发表于 2025-3-22 10:44:50
Patrick M. Doran M.D.,Sundeep Khosla M.D.rgeons may use an anterior approach (AA) for these patients, with parenchymal transection starting from the anterior surface of the liver toward the inferior vena cava (IVC). However, this anterior approach has a problem of controlling bleeding from the deeper liver parenchymal tissue because of poo
DEFER
发表于 2025-3-22 13:04:16
https://doi.org/10.1007/978-1-4615-5241-3ease in the liver is the primary cause of disease-specific death. The choices of effective treatment include liver resection and ablation and interventional radiology procedures, including chemoembolization and intra-arterial injection of radioactive spheres. Optimal treatment involves a combination
DEFER
发表于 2025-3-22 20:38:51
http://reply.papertrans.cn/23/2224/222315/222315_7.png
运气
发表于 2025-3-22 21:25:10
https://doi.org/10.1007/978-1-4615-5247-5es who could not be radically resected while leaving an adequate liver remnant in one operation. Despite the need of two separate surgeries, it provides an optimal oncological selection based on response to chemotherapy and absence of rapid progression between stages, and a safe approach to major he
咆哮
发表于 2025-3-23 03:03:31
N. D. Harris,S. Ibrahim,M. Radatz,J. D. Wardable due to the extent of hepatic disease or a small future liver remnant (FLR). When size of FLR is regarded to be not sufficient to sustain liver function in the postoperative course, techniques of portal vein occlusion (PVO) such as portal vein embolization (PVE) or portal vein ligation (PVL) can
支形吊灯
发表于 2025-3-23 09:14:02
,Control Concepts and Operations with PC’s,he liver. Successful completion of treatment to all sites of disease is the only chance of cure and is associated with 5-year survival of 55%. Uncertainty remains regarding the optimal sequencing of therapy, the applicability of synchronous resections and the role of pelvic radiotherapy in stage IV